Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Lung cancer is primarily caused by damage to the cells lining the lungs, most commonly triggered by long-term exposure to tobacco smoke. While environmental and genetic factors also play a critical role, the development of lung cancer is a complex process involving the accumulation of DNA mutations that cause cells to grow uncontrollably. What are the primary causes of lung cancer? The development of lung cancer is rarely due to a single event; instead, it is usually the result of long-term exposure to carcinogens.
TL;DR: Lung cancer is primarily caused by damage to the cells lining the lungs, most commonly triggered by long-term exposure to tobacco smoke. While environmental and genetic factors also play a critical role, the development of lung cancer is a complex process involving the accumulation of DNA mutations that cause cells to grow uncontrollably.
The development of lung cancer is rarely due to a single event; instead, it is usually the result of long-term exposure to carcinogens. When these substances enter the lungs, they damage the DNA of healthy cells. Over time, these mutations disable the "brakes" that normally stop cells from dividing, allowing a tumor to form. While smoking is the leading cause, lung cancer can also develop in individuals who have never smoked due to secondary environmental factors.
A risk factor increases the likelihood of developing a disease, while a cause is the direct biological trigger. Major risk factors for lung cancer include:
While lung cancer itself is not strictly an inherited disease, genetic predisposition can influence susceptibility. Researchers have identified specific inherited mutations and chromosomal variations that may make some individuals more sensitive to the DNA-damaging effects of carcinogens. However, most mutations associated with lung cancer are "somatic," meaning they are acquired during a person's lifetime rather than passed down from parents.
Scientists are currently using genomic sequencing to better understand the molecular landscape of lung cancer. Research is focused on identifying "driver mutations" (such as EGFR, ALK, and KRAS) that act as the primary engine for tumor growth. Understanding these specific mutations is vital for developing targeted therapies that treat the cancer at its genetic source.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.